Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

In This Article:

Revenue of $586.0 million, up 111% year-over-year in Q1 2025

Net income of $49.5 million; Adjusted EBITDA of $91.1 million in Q1 2025

Subscribers grew to 2.4 million, up 38% year-over-year in Q1 2025

Affirms full year 2025 revenue guidance of $2.3 billion to $2.4 billion and raises Adjusted EBITDA guidance to a range of $295 million to $335 million

Introduces 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA

SAN FRANCISCO, May 05, 2025--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2025, in a shareholder letter that is posted at investors.hims.com.

"We’re starting 2025 with incredible momentum. Millions of people are turning to us for access to care that is personal, affordable, and has the potential to drive better outcomes," said Andrew Dudum, co-founder and CEO. "We’re building a platform that puts the individual at the center of every decision and others are taking notice. Over time, we expect wider collaboration across the industry, inclusive of pharmaceutical players, innovative leaders in diagnostic and preventative testing, and world class providers. We believe this will strengthen our ecosystem and position us to curate a best-in-class offering that can reach tens of millions of people. This is the future of our platform, allowing a historically disjointed industry to reach more consumers, for the benefit of those consumers."

Yemi Okupe, CFO, stated, "During the first quarter, our subscriber base grew to nearly 2.4 million, with over 1.4 million utilizing personalized solutions. Revenue increased 111% year-over-year as we continued to deliver access to more precise, personalized care at scale. This momentum, combined with our strong track record of execution, reinforces our confidence in driving sustained long-term growth across five core levers: deepening personalization, expanding into new specialties, elevating the subscriber experience with access to high quality follow up care, forging innovative partnerships, and entering new geographies. Investments across these priorities underpin our updated 2025 guidance as well as our new long-term targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030."

Key Business Metrics

(In Thousands, Except for Monthly Online Revenue per Average Subscriber, Unaudited)

 

 

 

Three Months Ended March 31,

 

 

2025

 

2024

 

% Change

Subscribers (end of period)

 

 

2,366

 

 

1,709

 

38

%

Monthly Online Revenue per Average Subscriber

 

$

84

 

$

55

 

53

%

Revenue

(In Thousands, Unaudited)

 

 

 

Three Months Ended March 31,

 

 

2025

 

2024

 

% Change

Online Revenue

 

$

576,361

 

$

267,761

 

115

%

Wholesale Revenue

 

 

9,649

 

 

10,410

 

(7

)%

Total revenue

 

$

586,010

 

$

278,171

 

111

%

First Quarter 2025 Financial Highlights

  • Revenue was $586.0 million for the first quarter of 2025 compared to $278.2 million for the first quarter of 2024, an increase of 111% year-over-year.

  • Gross margin was 73% for the first quarter of 2025 compared to 82% for the first quarter of 2024.

  • Net income was $49.5 million for the first quarter of 2025 compared to $11.1 million for the first quarter of 2024.

  • Adjusted EBITDA was $91.1 million for the first quarter of 2025 compared to $32.3 million for the first quarter of 2024.

  • Net cash provided by operating activities was $109.1 million for the first quarter of 2025 compared to $25.8 million for the first quarter of 2024.

  • Free Cash Flow was $50.1 million for the first quarter of 2025 compared to $11.9 million for the first quarter of 2024.